+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Alexion Pharmaceuticals - logo

Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare diseases. Alexion developed Soliris for the treatment of patients with paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. Soliris is approved in more than 50 countries for PNH and more than 40 countries for aHUS. Alexion's company headquarters are based Cheshire, Connecticut, United States.

Drug Formulation Market Report 2025 - Product Thumbnail Image

Drug Formulation Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
Guillain-Barré Syndrome (GBS) - Pipeline Insight, 2025 - Product Thumbnail Image

Guillain-Barré Syndrome (GBS) - Pipeline Insight, 2025

  • Clinical Trials
  • March 2025
  • 60 Pages
  • Global
From
From
Wilson Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Wilson Disease - Pipeline Insight, 2024

  • Clinical Trials
  • November 2024
  • 60 Pages
  • Global
From
From
Orphan Drugs Market Report 2025 - Product Thumbnail Image

Orphan Drugs Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Generalized Myasthenia Gravis (gMG) - Pipeline Insight, 2024 - Product Thumbnail Image

Generalized Myasthenia Gravis (gMG) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Danicopan Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Danicopan Emerging Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
From
AL Amyloidosis Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

AL Amyloidosis Treatment Market Report and Forecast 2023-2031

  • Report
  • March 2023
  • 147 Pages
  • Global
From
From
From
Loading Indicator